C4 Therapeutics, Inc.
CCCCCIK 0001662579 · last filing Jul 2, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
5,991 bought / 0 sold
net +5,991 sh · +$26.0K
- buys
- 2
- sells
- 0
- insiders active
- 2
Filing tape
Filed Thu, Jul 2, 2026
- +3,341 sh · $14.5K
Grogan Donna Roy — Director
- Granted3,341Common Stock@ $4.34→ 74,853 held
- +2,650 sh · $11.5K
Anderson Kenneth Carl — Director
- Granted2,650Common Stock@ $4.34→ 71,950 held
Insiders on this tape
- Grogan Donna RoyDirector
- Anderson Kenneth CarlDirector
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.